NCT05825300

Brief Summary

The goal of this study is to test whether emails that inform patients they have a blood type in need are more effective at encouraging patients to schedule and attend blood donation appointments, compared to email messages that do not mention the patient has a blood type in need.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40,486

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

April 10, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 3, 2023

Completed
Last Updated

July 6, 2023

Status Verified

July 1, 2023

Enrollment Period

3 months

First QC Date

April 10, 2023

Last Update Submit

July 3, 2023

Conditions

Behavior, Health

Keywords

Blood donation

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Attended a Donation Appointment

    Attended a donation appointment within 6 weeks of their message send date, regardless of whether they donated. This outcome includes patients who were unable to donate for any reason (e.g., low hemoglobin) or patients who showed up to the appointment but decided to leave before donating.

    Within 6 weeks of the patient's message send date

Other Outcomes (3)

  • Number of Participants Who Successfully Donated Blood

    Within 6 weeks of the patient's message send date

  • Number of Participants Who Scheduled a Blood Donation Appointment

    Within 2 weeks of the patient's message send date

  • Number of Participants Who Scheduled a Blood Donation Appointment

    Within 6 weeks of the patient's message send date

Study Arms (2)

No-blood-type message

EXPERIMENTAL

This group will receive a message that does not mention that the patient's blood type is in short supply.

Behavioral: Email message

Blood-type message

EXPERIMENTAL

This group will receive a message that states their blood type is in short supply.

Behavioral: Email messageBehavioral: Social responsibility

Interventions

Email messageBEHAVIORAL

Email message encourages patients to donate blood

Blood-type messageNo-blood-type message
Social responsibilityBEHAVIORAL

Message specifies that there is a shortage of the patient's blood type

Blood-type message

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Documented blood type in short supply
  • Age 18+
  • Can be contacted via email

You may not qualify if:

  • Hemoglobin test result \< 12.5 within the 3 months prior to list creation
  • Shares an email address with a patient of a different needed blood type
  • Email address associated with at least one previous donor and one non-previous donor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger Clinic

Danville, Pennsylvania, 17822, United States

Location

MeSH Terms

Conditions

Health Behavior

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Amir Goren, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Masking Details
The patients in the study will not know that other messages are being sent to other patients, although they will see the text of their own message. Providers will be blind to patient conditions.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Program Director, Behavioral Insights Team

Study Record Dates

First Submitted

April 10, 2023

First Posted

April 24, 2023

Study Start

April 10, 2023

Primary Completion

July 3, 2023

Study Completion

July 3, 2023

Last Updated

July 6, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will become available after publication of study results in a scientific journal and will be available as long as the Open Science Framework hosts the data.
Access Criteria
The data on the Open Science Framework will be open to anyone requesting that information.

Locations

US(1)